Boston Scientific (BSX)
NYSEHealth CareMedical DevicesSnapshot 2026-07-08
$44.80-1.09%
Close 2026-07-08 · 1-day change
Reading BSX? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track BSX free→NYSEHealth CareMedical DevicesSnapshot 2026-07-08
Reading BSX? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track BSX free→QuarterlyIQ Insights · BSX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||||
| Revenues | 20,614.0 | 20,074.0 | 16,747.0 | 14,240.0 | 12,682.0 | 11,888.0 | 9,913.0 | 10,735.0 | 8,386.0 | 8,386.0 | 9,076.0 | 8,068.0 | 6,958.0 | 7,249.0 | 7,249.0 | 7,622.0 | 8,050.0 | 8,050.0 |
| Total Revenues | — | — | — | — | — | — | — | — | — | 8,386.0 | 9,076.0 | 8,068.0 | 6,958.0 | 7,249.0 | 7,249.0 | 7,622.0 | 8,050.0 | 8,050.0 |
| Cost of Revenues | 6,358.0 | 6,221.0 | 5,257.0 | 4,345.0 | 3,956.0 | 3,711.0 | 3,465.0 | 3,116.0 | 2,424.0 | 2,424.0 | 2,424.0 | 2,173.0 | 2,349.0 | 2,349.0 | 2,349.0 | 2,659.0 | 2,469.0 | 2,469.0 |
| Gross Profit | 14,258.0 | 13,854.0 | 11,490.0 | 9,896.0 | 8,727.0 | 8,177.0 | 6,448.0 | 7,620.0 | 5,962.0 | 5,962.0 | 5,962.0 | 5,304.0 | 4,900.0 | 4,900.0 | 4,900.0 | 4,963.0 | 5,581.0 | 5,581.0 |
| Operating Expenses & Income | ||||||||||||||||||
| Selling, General & Admin | 7,071.0 | 6,887.0 | 5,984.0 | 5,190.0 | 4,520.0 | 4,359.0 | 3,787.0 | 3,941.0 | 3,099.0 | 3,099.0 | 3,099.0 | 2,873.0 | 2,535.0 | 2,535.0 | 2,535.0 | 2,487.0 | 2,589.0 | 2,589.0 |
| Other Operating Expenses, Total | — | — | 16.0 | 93.0 | 38.0 | (218.0) | (362.0) | — | — | — | — | — | — | — | — | — | — | — |
| Operating Income | 3,793.0 | 3,613.0 | 2,603.0 | 2,343.0 | 1,649.0 | 1,199.0 | (80.0) | 1,518.0 | 447.0 | 447.0 | 447.0 | (327.0) | (3,868.0) | (3,868.0) | (3,868.0) | 904.0 | (1,505.0) | (1,505.0) |
| Earnings from Continuing Operations | ||||||||||||||||||
| Interest Expense | 357.0 | 349.0 | 305.0 | 265.0 | 470.0 | 341.0 | 361.0 | 473.0 | 233.0 | 233.0 | 233.0 | 284.0 | 261.0 | 261.0 | 261.0 | 281.0 | 468.0 | 468.0 |
| Other Non-Operating Income / Expenses | — | — | — | (358.0) | (508.0) | (123.0) | 1.0 | (831.0) | (270.0) | (270.0) | (270.0) | (323.0) | — | — | (239.0) | (262.0) | (526.0) | — |
| Asset Writedown | — | — | — | — | — | — | — | — | — | — | 110.0 | 19.0 | 195.0 | 4,492.0 | 4,492.0 | 718.0 | 1,882.0 | — |
| EBT, Incl. Unusual Items | 3,742.0 | 3,385.0 | 2,282.0 | 1,985.0 | 1,141.0 | 1,076.0 | (79.0) | 687.0 | 177.0 | 177.0 | 177.0 | (650.0) | (4,107.0) | (4,107.0) | (4,107.0) | 642.0 | (2,031.0) | (2,031.0) |
| Income Tax Expense | 184.0 | 493.0 | 436.0 | 393.0 | 443.0 | 36.0 | 2.0 | (4,013.0) | (170.0) | (170.0) | (170.0) | (411.0) | (39.0) | (39.0) | (39.0) | 201.0 | 5.0 | 5.0 |
| Net Income | ||||||||||||||||||
| Minority Interest | (6.0) | (6.0) | (8.0) | (1.0) | 0.0 | 0.0 | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Income | 3,559.0 | 2,892.0 | 1,846.0 | 1,592.0 | 698.0 | 1,041.0 | (82.0) | 4,700.0 | 347.0 | 347.0 | 347.0 | (239.0) | (4,068.0) | (4,068.0) | (4,068.0) | 441.0 | (2,036.0) | (2,036.0) |
| Per Share | ||||||||||||||||||
| Basic EPS | 2.40 | 1.96 | 1.26 | 1.08 | 0.45 | 0.69 | (0.08) | 3.38 | 0.26 | 0.26 | 0.26 | (0.18) | (2.89) | (2.89) | (2.89) | 0.29 | (1.36) | (1.36) |
| Diluted EPS | 2.38 | 1.94 | 1.25 | 1.07 | 0.45 | 0.69 | (0.08) | 3.33 | 0.25 | 0.25 | 0.25 | (0.18) | (2.89) | (2.89) | (2.89) | 0.29 | (1.36) | (1.36) |
| Revenue per Share | 13.79 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 1,484.9 | 1,480.4 | 1,471.5 | 1,453.0 | 1,430.5 | 1,422.3 | 1,416.7 | 1,391.5 | 1,357.6 | 1,357.6 | 1,357.6 | 1,341.2 | 1,406.7 | 1,406.7 | 1,406.7 | 1,509.3 | 1,498.5 | 1,498.5 |
| Diluted Weighted Avg Shares | 1,495.0 | 1,494.5 | 1,485.9 | 1,463.5 | 1,439.7 | 1,433.8 | 1,416.7 | 1,410.6 | 1,377.2 | 1,377.2 | 1,377.2 | 1,341.2 | 1,406.7 | 1,406.7 | 1,406.7 | 1,519.0 | 1,498.5 | 1,498.5 |
| Supplemental | ||||||||||||||||||
| EBITDA | — | 4,981.0 | 3,872.0 | 3,539.0 | 2,785.0 | 2,292.0 | 1,043.0 | 2,529.0 | 1,262.0 | 1,262.0 | 1,262.0 | 442.0 | (3,185.0) | (3,185.0) | (3,185.0) | 1,621.0 | (641.0) | (641.0) |
| EBIT | 3,793.0 | 3,613.0 | 2,603.0 | 2,343.0 | 1,649.0 | 1,199.0 | (80.0) | 1,518.0 | 447.0 | 447.0 | 447.0 | (327.0) | (3,868.0) | (3,868.0) | (3,868.0) | 904.0 | (1,505.0) | (1,505.0) |
| Effective Tax Rate | 4.9% | 14.6% | 19.1% | 19.8% | 38.8% | 3.3% | -2.5% | -584.1% | -96.0% | -96.0% | -96.0% | 63.2% | 0.9% | 0.9% | 0.9% | 31.3% | -0.2% | -0.2% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.